Bone Metabolism in Patients with Hidradenitis Suppurativa: A Case-control Study
DOI:
https://doi.org/10.2340/actadv.v102.3504Keywords:
hidradenitis suppurativa, metabolic bone diseases, bone density, 25-hydroxyvitamin DAbstract
Hidradenitis suppurativa (HS) is a chronic inflammatory disease of the hair follicles. The aim of this case-control study was to assess whether HS is associated with disturbances in trabecular bone score, bone mineral density, bone remodelling markers, and calciotropic hormones. A total of 81 patients and 79 controls of similar age and sex were included. Demographic, anthropometric, laboratory data, trabecular bone score, bone mineral density, serum 25-hydroxyvitamin D (25OHD), serum amino-terminal pro-peptide of type 1 collagen (PINP), and C-terminal telopeptide of type 1 collagen (CTX) concentrations were assessed in both groups. Patients with HS had lower serum 25OHD levels than controls, and approximately 62% of them had vitamin D deficiency. Serum PINP was increased and CTX was decreased in patients with HS. Fully adjusted trabecular bone score values were lower in patients with HS compared with controls. Adjusted lumbar bone mineral density was similar in HS and controls, whilst total hip bone mineral density was lower in patients with HS. There were no statistical differences regarding disease severity in terms of 25OHD, serum turnover markers, bone mineral density, or trabecular bone score values. This study shows that patients with HS have lower trabecular bone score and total hip bone mineral density values than population-based controls. In addition, the prevalence of vitamin D deficiency is high in subjects with HS.
Downloads
References
Alikhan A, Lynch P, Eisen D. Hidradenitis suppurativa: a comprehensive review. J Am Acad Dermatol 2009; 60: 539-561.
https://doi.org/10.1016/j.jaad.2008.11.911 DOI: https://doi.org/10.1016/j.jaad.2008.11.911
Alavi A, Anooshirvani N, Kim W, Coutts P, Sibbald R. Quality-of-life impairment in patients with hidradenitis suppurativa: a Canadian study. Am J Clin Dermatol 2015; 16: 61-65.
https://doi.org/10.1007/s40257-014-0105-5 DOI: https://doi.org/10.1007/s40257-014-0105-5
Dunstan RW, Salte KM, Todorović V, Lowe M, Wetter JB, Harms PW, et al. Histologic progression of acne inversa/hidradenitis suppurativa: implications for future investigations and therapeutic intervention. Exp Dermatol 2021; 30: 820-830.
https://doi.org/10.1111/exd.14273 DOI: https://doi.org/10.1111/exd.14273
Frew J., Hawkes J, Krueger J. A systematic review and critical evaluation of inflammatory cytokine associations in hidradenitis suppurativa. F100Res 2018; 7: 1930.
https://doi.org/10.12688/f1000research.17267.1 DOI: https://doi.org/10.12688/f1000research.17267.1
Shah A, Alhusayen R, Amini-Nik S. The critical role of macrophages in the pathogenesis of hidradenitis suppurativa. Inflamm Res 2017; 66: 931-945.
https://doi.org/10.1007/s00011-017-1074-y DOI: https://doi.org/10.1007/s00011-017-1074-y
Moran B, Sweeney CM, Hughes R, Malara A, Kirthi S, Tobin AM, et al. Hidradenitis suppurativa is characterized by dysregulation of the Th17: Treg cell axis, which is corrected by anti-TNF therapy. J Invest Dermatol 2017; 137: 2389-2295.
https://doi.org/10.1016/j.jid.2017.05.033 DOI: https://doi.org/10.1016/j.jid.2017.05.033
Salgado-Boquete L, Romaní J, Carrión L, Marín-Jiménez I. Epidemiology of hidradenitis suppurativa and inflammatory bowel disease: are these two diseases associated? Actas Dermosifiliogr 2016; 107: 8-12.
https://doi.org/10.1016/S0001-7310(17)30003-0 DOI: https://doi.org/10.1016/S0001-7310(17)30003-0
Vinkel C, Thomsen SF. Autoinflammatory syndromes associated with hidradenitis suppurativa and/or acne. Int J Dermatol 2017; 56: 811-818.
https://doi.org/10.1111/ijd.13603 DOI: https://doi.org/10.1111/ijd.13603
Hardy R, Cooper MS. Bone loss in inflammatory disorders. J Endocrinol 2009; 201: 309-320.
https://doi.org/10.1677/JOE-08-0568 DOI: https://doi.org/10.1677/JOE-08-0568
Schett G, Kiechl S, Weger S, Pederiva A, Mayr A, Petrangeli M, et al. High-sensitivity C-reactive protein and risk of nontraumatic fractures in the Bruneck study. Arch Intern Med 2006; 166: 2495-2501.
https://doi.org/10.1001/archinte.166.22.2495 DOI: https://doi.org/10.1001/archinte.166.22.2495
Ruaro B, Casabella A, Paolino S, Pizzorni C, Alessandri E, Seriolo C, et al. Correlation between bone quality and microvascular damage in systemic sclerosis patients. Rheumatology 2018; 57: 1548-1554.
https://doi.org/10.1093/rheumatology/key130 DOI: https://doi.org/10.1093/rheumatology/key130
Toussirot E, Mourot L, Wendling D, Dumoulin G. Trabecular bone score in rheumatoid arthritis and ankylosing spondylitis and changes during long-term treatment with TNF-α blocking agents. Ann Rheum Dis 2013 72: A1008-A1009.
https://doi.org/10.1136/annrheumdis-2013-eular.3044 DOI: https://doi.org/10.1136/annrheumdis-2013-eular.3044
Ruaro B, Casabella A, Paolino S, Alessandri E, Patané M, Gotelli E, et al. Trabecular bone score and bone quality in systemic lupus erythematosus patients. Front Med (Lausanne) 2020; 7: 574842.
https://doi.org/10.3389/fmed.2020.574842 DOI: https://doi.org/10.3389/fmed.2020.574842
Ammann P, Rizzoli R. Bone strength and its determinants. Osteoporos Int 2003; 14: S13-S18.
https://doi.org/10.1007/s00198-002-1345-4 DOI: https://doi.org/10.1007/s00198-002-1345-4
Bonnick SL. Dual-energy x-ray absorptiometry: interpreting reports and serial measurements. Clin Obstet Gynecol 2013; 56: 677-685.
https://doi.org/10.1097/GRF.0b013e3182a8240c DOI: https://doi.org/10.1097/GRF.0b013e3182a8240c
Silva BC, Leslie WD, Resch H, Lamy O, Lesnyak O, Binkley N, et al. Trabecular bone score: a noninvasive analytical method based upon the DXA image. J Bone Miner Res 2014; 29: 518-530.
https://doi.org/10.1002/jbmr.2176 DOI: https://doi.org/10.1002/jbmr.2176
Olmos JM, Hernández JL, García-Velasco P, Martínez P, Llorca J, González-Macías J. Serum 25-hydroxyvitamin D, parathyroid hormone, calcium intake, and bone mineral density in Spanish adults. Osteoporos Int 2016; 27: 105-113.
https://doi.org/10.1007/s00198-015-3219-6 DOI: https://doi.org/10.1007/s00198-015-3219-6
Martínez J, Olmos JM, Hernández JL, Pinedo G, Llorca J, Obregon E, et al. Bone turnover markers in Spanish postmenopausal women: the Camargo cohort study. Clin Chim Acta 2009; 409: 70-74.
https://doi.org/10.1016/j.cca.2009.08.020 DOI: https://doi.org/10.1016/j.cca.2009.08.020
National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation 2020; 106: 3143-3421.
https://doi.org/10.1161/circ.106.25.3143 DOI: https://doi.org/10.1161/circ.106.25.3143
Kimball AB, Kerdel F, Adams D, Mrowietz U, Gelfand JM, Gniadecki R, et al. Adalimumab for the treatment of moderate to severe hidradenitis suppurativa: a parallel randomized trial. Ann Intern Med 2012; 157: 846-855.
https://doi.org/10.7326/0003-4819-157-12-201212180-00004 DOI: https://doi.org/10.7326/0003-4819-157-12-201212180-00004
Hurley HJ. Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurativa and familial benign pemphigus. Surgical approach. In: Roenigk and Roenigk's Dermatologic Surgery, Principles and Practice, 2nd edn. New York: Marcel Dekker, 1989: p. 623-646.
Zouboulis CC, Tzellos T, Kyrgidis A, Jemec GBE, Bechara FG, Giamarellos-Bourboulis EJ, et al; European Hidradenitis Suppurativa Foundation Investigator Group. Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity. Br J Dermatol 2017; 177: 1401-1409.
https://doi.org/10.1111/bjd.15748 DOI: https://doi.org/10.1111/bjd.15748
Del Rio LM, Winzenrieth R, Cormier C, Di Gregorio S. Is bone microarchitecture status of the lumbar spine assessed by TBS related to femoral neck fracture? A Spanish case-control study, Osteoporos Int 2013; 24: 991-998.
https://doi.org/10.1007/s00198-012-2008-8 DOI: https://doi.org/10.1007/s00198-012-2008-8
McCloskey EV, Odén A, Harvey NC, Leslie WD, Hans D, Johansson H, et al. A meta-analysis of trabecular bone score in fracture risk prediction and its relationship to FRAX. J Bone Miner Res 2016; 31: 940-948.
https://doi.org/10.1002/jbmr.2734 DOI: https://doi.org/10.1002/jbmr.2734
Hernández JL, López-Mejías R, Blanco R, Pina T, Ruiz S, Sierra I, et al. Association of trabecular bone score with inflammation and adiposity in patients with psoriasis: effect of adalimumab therapy. J Osteoporos 2016; 2016: 5747852.
https://doi.org/10.1155/2016/5747852 DOI: https://doi.org/10.1155/2016/5747852
Richards C, Leslie WD. Trabecular bone score in rheumatic disease. Curr Rheumatol Rep 2022; 24: 81-87.
https://doi.org/10.1007/s11926-022-01062-w DOI: https://doi.org/10.1007/s11926-022-01062-w
Senosi MR, Fathi HM, Baki NMA, Zaki O, Magdy AM, Gheita TA. Bone mineral density, vitamin D receptor (VDR) gene polymorphisms, fracture risk assessment (FRAX), and trabecular bone score (TBS) in rheumatoid arthritis patients: connecting pieces of the puzzle. Clin Rheumatol 2022; 41: 1333-1342.
https://doi.org/10.1007/s10067-022-06048-8 DOI: https://doi.org/10.1007/s10067-022-06048-8
Almuhanna N, Finstad A, Alhusayen R. Association between hidradenitis suppurativa and inflammatory arthritis: a systematic review and meta-analysis. Dermatology 2021; 237: 740-747.
https://doi.org/10.1159/000514582 DOI: https://doi.org/10.1159/000514582
Killinger Z, Gajdarova L, Kuzma M, Krajcovicova A, Brazdilova K, Jackuliak P, et al. Biologic treatment in comparison to methotrexate has a positive effect on trabecular bone score in rheumatoid arthritis patients: 1-year follow-up. Acta Clin Belg 2019; 74: 121-125.
https://doi.org/10.1080/17843286.2018.1512189 DOI: https://doi.org/10.1080/17843286.2018.1512189
Kelly G, Sweeney CM, Fitzgerald R, O'Keane MP, Kilbane M, Lally A, et al. Vitamin D status in hidradenitis suppurativa. Br J Dermatol 2014; 170: 1379-1380.
https://doi.org/10.1111/bjd.12900 DOI: https://doi.org/10.1111/bjd.12900
Karagiannidis I, Nikolakis G, Sabat R, Zouboulis CC. Hidradenitis suppurativa/acne inversa: an endocrine skin disorder? Rev Endocr Metab Disord 2016; 17: 335-341.
https://doi.org/10.1007/s11154-016-9366-z DOI: https://doi.org/10.1007/s11154-016-9366-z
Guillet A, Brocard A, Bach Ngohou K, Graveline N, A-G, Ali D, et al. Verneuil's disease, innate immunity, and vitamin D: a pilot study. J Eur Acad Dermatol Venereol 2015; 29: 1347-1353.
https://doi.org/10.1111/jdv.12857 DOI: https://doi.org/10.1111/jdv.12857
Fabbrocini G, Marasca C, Luciano MA, Guarino M, Poggi S, Fontanella G, et al. Vitamin D deficiency and hidradenitis suppurativa: the impact on clinical severity and therapeutic responsivity. J Dermatolog Treat 2021; 32: 843-844.
https://doi.org/10.1080/09546634.2020.1714538 DOI: https://doi.org/10.1080/09546634.2020.1714538
Brandao L, Moura R, Tricarico PM, Gratton R, Genovese G, Moltrasio C, et al. Altered keratinization and vitamin D metabolism may be key pathogenetic pathways in syndromic hidradenitis suppurativa: a novel whole-exome sequencing approach. J Dermatol Sci 2020; 99: 17-22.
https://doi.org/10.1016/j.jdermsci.2020.05.004 DOI: https://doi.org/10.1016/j.jdermsci.2020.05.004
Umar M, Sastry KS, Al Ali F, Al-Khulaifi M, Wang E, Chouchane AI. Vitamin D and the pathophysiology of inflammatory skin diseases. Skin Pharmacol Physiol 2018; 31: 74-86.
https://doi.org/10.1159/000485132 DOI: https://doi.org/10.1159/000485132
Antal AS, Dombrowski Y, Koglin S, Ruzicka T, Schauber J. Impact of vitamin D3 on cutaneous immunity and antimicrobial peptide expression. Dermatoendocrinol 2011; 3: 18-22.
https://doi.org/10.4161/derm.3.1.14616 DOI: https://doi.org/10.4161/derm.3.1.14616
Sadeghi K, Wessner B, Laggner U, Ploder M, Tamandl D, Friedl J, et al. Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. Eur J Immunol 2006; 36: 361-370.
https://doi.org/10.1002/eji.200425995 DOI: https://doi.org/10.1002/eji.200425995
Baker-LePain JC, Nakamura MC, Lane NE. Effects of inflammation on bone: an update. Curr Opin Rheumatol 2011; 23: 389-395.
https://doi.org/10.1097/BOR.0b013e3283474dbe DOI: https://doi.org/10.1097/BOR.0b013e3283474dbe
Diarra D, Stolina M, Polzer K, Zwerina J, MS, Dwyer D, et al. Dickkopf-1 is a master regulator of joint remodeling. Nat Med 2007; 13: 156-163.
https://doi.org/10.1038/nm1538 DOI: https://doi.org/10.1038/nm1538
Gilbert L, He X, Farmer P, Boden S, Kozlowski M, Rubin J, Nanes MS. Inhibition of osteoblast differentiation by tumor necrosis factor-alpha. Endocrinology 2000; 141: 3956-3964.
https://doi.org/10.1210/endo.141.11.7739 DOI: https://doi.org/10.1210/endo.141.11.7739
Wang H, Young SR, Gerard-O'Riley R, JM, Yang Z, Joseph P Bidwell JP, et al. Blockade of TNFR1 signaling: a role of oscillatory fluid shear stress in osteoblasts. J Cell Physiol 2011; 226: 1044-1051.
https://doi.org/10.1002/jcp.22427 DOI: https://doi.org/10.1002/jcp.22427
Arends S, Spoorenberg A, Houtman PM, Leijsma MK, Bos R, et CG, et al. The effect of three years of TNF-α blocking therapy on markers of bone turnover and their predictive value for treatment discontinuation in patients with ankylosing spondylitis: a prospective longitudinal observational cohort study. Arthritis Res Ther 2012; 14: R98.
https://doi.org/10.1186/ar3823 DOI: https://doi.org/10.1186/ar3823
Vis M, Wolbink GJ, Lodder MC, Kostense PJ, van de Stadt RJ, de Koning MH, et al. Early changes in bone metabolism in rheumatoid arthritis patients treated with infliximab. Arthritis Rheum 2003; 48: 2996-2997.
https://doi.org/10.1002/art.11292 DOI: https://doi.org/10.1002/art.11292
Gulyás K, Horváth Á, Végh E, Pusztai A, Szentpétery Á, Pethö Z, et al. Effects of 1-year anti-TNF-α therapies on bone mineral density and bone biomarkers in rheumatoid arthritis and ankylosing spondylitis. Clin Rheumatol 2020; 39: 167-175.
https://doi.org/10.1007/s10067-019-04771-3 DOI: https://doi.org/10.1007/s10067-019-04771-3
Jorde R, Stunes AK, Kubiak J, Grimnes G, Thorsby PM, Syversen U. Smoking and other determinants of bone turnover. PLoS One 2019; 14: e0225539.
https://doi.org/10.1371/journal.pone.0225539 DOI: https://doi.org/10.1371/journal.pone.0225539
Al-Bashaireh AM, Alqudah O. Comparison of bone turnover markers between young adult male smokers and nonsmokers. Cureus 2020 27; 12: e6782.
https://doi.org/10.7759/cureus.6782 DOI: https://doi.org/10.7759/cureus.6782
González-López MA, Vilanova I, Ocejo-Viñals G, Arlegui R, Navarro I, Guiral S, et al. Circulating levels of adiponectin, leptin, resistin and visfatin in non-diabetics patients with hidradenitis suppurativa. Arch Dermatol Res 2020; 312: 595-600.
https://doi.org/10.1007/s00403-019-02018-4 DOI: https://doi.org/10.1007/s00403-019-02018-4
Neumann E, Junker S, Schett G, Frommer K, Müller-Ladner U. Adipokines in bone disease. Nat Rev Rheumatol 2016; 12: 296-302.
https://doi.org/10.1038/nrrheum.2016.49 DOI: https://doi.org/10.1038/nrrheum.2016.49
González-López MA, Ocejo-Viñals JG, Mata C, Diaz S, Guiral S, Portilla V, et al. Evaluation of serum omentin-1 and apelin concentrations in patients with hidradenitis suppurativa. Postepy Dermatol Alergol 2021; 38: 450-454.
https://doi.org/10.5114/ada.2021.107932 DOI: https://doi.org/10.5114/ada.2021.107932
Published
How to Cite
License
Copyright (c) 2022 Iñigo Navarro, Marcos A. González-López, Isabel Sierra, Jose Manuel Olmos, Ricardo Blanco, Jose Luis Hernández
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
